Published:
Last updated:
zie samenvatting
ID
NL-OMON31098
Source
ToetsingOnline
Brief title
BOSOM (Breast cancer Outcome Of Mutation carriers)
Condition
- Breast neoplasms malignant and unspecified (incl nipple)
Synonym
breast cancer
Research involving
Human
Sponsors and support
Primary sponsor
:
Nederlands Kanker Instituut
Source(s) of monetary or material Support
:
KWF
Intervention
Keyword
:
breast cancer, germline mutations, survival, tumor charateristics
Outcome measures
Primary outcome
zie samenvatting
Secondary outcome
zie samenvatting
Background summary
zie samenvatting
Study objective
zie samenvatting
Study design
zie samenvatting
Study burden and risks
zie samenvatting
Public
Nederlands Kanker Instituut
Plesmanlaan 121
1066 CX
NL
Plesmanlaan 121
1066 CX
NL
Scientific
Nederlands Kanker Instituut
Plesmanlaan 121
1066 CX
NL
Plesmanlaan 121
1066 CX
NL
Listed location countries
Netherlands
Age
Adults (18-64 years)
Elderly (65 years and older)
Inclusion criteria
period 1995-2002
age <50 years
invasive breast cancer
Exclusion criteria
earlier malignancy
Design
Study type
:
Observational invasive
Intervention model
:
Other
Allocation
:
Non-randomized controlled trial
Masking
:
Open (masking not used)
Control
:
Active
Primary purpose
:
Basic science
Recruitment
NL
Recruitment status
:
Pending
Start date (anticipated)
:
Enrollment
:
800
Type
:
Anticipated
Approved WMO
Application type
:
First submission
Review commission
:
METC Universitair Medisch Centrum Utrecht (Utrecht)
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL19270.031.07 |